Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Moss

Showing results (361-370 of 369) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 369 results.
Stem Cells (Dayton, Ohio)|May 14, 2013
Fetal deficiency of lin28 programs life-long aberrations in growth and glucose metabolismGen Shinoda, Ng Shyh-Chang, T Yvanka de Soysa, et al.
Genetics|November 5, 2021
An engineered, orthogonal auxin analog/AtTIR1(F79G) pairing improves both specificity and efficacy of the auxin degradation system in Caenorhabditis elegansKelly Hills-Muckey, Michael A Q Martinez, Natalia Stec, et al.
Plos One|July 12, 2013
Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesionsAlastair J King, Marc R Arnone, Maureen R Bleam, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven TumorsTara R Rheault, John C Stellwagen, George M Adjabeng, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Highly Potent and Selective MEK Inhibitor: GSK1120212 (JTP-74057 DMSO Solvate)Hiroyuki Abe, Shinichi Kikuchi, Kazuhide Hayakawa, et al.
Journal of Cancer Policy|September 24, 2025
Promoting a research agenda for cancer treatment for intravenous devices with clinicians in Europe; the PRACTICE surveyCaitriona Duggan, Orlaith Hernon, Andrew J Simpkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationshipDirk B Mendel, A Douglas Laird, Xiaohua Xin, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 24, 2016
Renal artery sympathetic denervation: observations from the UK experienceAndrew S P Sharp, Justin E Davies, Melvin D Lobo, et al.
Molecular and Cellular Biology|November 17, 2001
New ways of initiating translation in eukaryotesR Schneider, V I Agol, R Andino, et al.
Pageof 37

Showing results (361-370 of 369) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 369 results.
Stem Cells (Dayton, Ohio)|May 14, 2013
Fetal deficiency of lin28 programs life-long aberrations in growth and glucose metabolismGen Shinoda, Ng Shyh-Chang, T Yvanka de Soysa, et al.
Genetics|November 5, 2021
An engineered, orthogonal auxin analog/AtTIR1(F79G) pairing improves both specificity and efficacy of the auxin degradation system in Caenorhabditis elegansKelly Hills-Muckey, Michael A Q Martinez, Natalia Stec, et al.
Plos One|July 12, 2013
Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesionsAlastair J King, Marc R Arnone, Maureen R Bleam, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven TumorsTara R Rheault, John C Stellwagen, George M Adjabeng, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Highly Potent and Selective MEK Inhibitor: GSK1120212 (JTP-74057 DMSO Solvate)Hiroyuki Abe, Shinichi Kikuchi, Kazuhide Hayakawa, et al.
Journal of Cancer Policy|September 24, 2025
Promoting a research agenda for cancer treatment for intravenous devices with clinicians in Europe; the PRACTICE surveyCaitriona Duggan, Orlaith Hernon, Andrew J Simpkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationshipDirk B Mendel, A Douglas Laird, Xiaohua Xin, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 24, 2016
Renal artery sympathetic denervation: observations from the UK experienceAndrew S P Sharp, Justin E Davies, Melvin D Lobo, et al.
Molecular and Cellular Biology|November 17, 2001
New ways of initiating translation in eukaryotesR Schneider, V I Agol, R Andino, et al.
Pageof 37